THE DEVELOPMENT OF MEDICATION THERAPY MANAGEMENT SYSTEM FOR DIABETIC OUTPATIENTS BY HOSxP PROGRAM AT WANG SAPUNG HOSPITAL, LOEI PROVINCE
DOI:
https://doi.org/10.69598/tbps.13.2.53-68Keywords:
medication therapy management, diabetes, drug-related problems, HOSxPAbstract
This quasi-experimental prospective research with a pre- and post-test design aims to develop a medication therapy management (MTM) system for diabetic outpatients by using the HOSxP program to record drug-related problems and communicate them to a physician at Wang Saphung Hospital, Loei Province. The inclusion criteria were T2DM patients with fasting blood sugar (FBS) ≥ 190 mg/dl and with evidence of 3 consecutive visits for treatment and follow-up during the period from December 2015 to September 2016 (n = 692). Drug-related problems (DRPs), understanding of the drugs, diabetes, and self-care management were the primary outcomes while FBS and blood pressure (BP) were the secondary outcome parameters. Repeated measure one-way ANOVA and Pearson correlation coefficient tests were employed for statistical analysis. The results demonstrated that the MTM system could improve the patients’ knowledge of medication use, diabetes, and self-care management. The system also decreased the number of DRPs, and improved the clinical outcome at a statistically significant result (p-value < 0.01). The absolute difference in the numbers of patients with FBS ≤ 130 mg/dl and BP < 130/80 mmHg, according to AHA/ACC recommendations at the 1st and 2nd MTM, were 32 (4.6%) and 31 (4.5%) respectively. Meanwhile, the number of patients with FBS ≤ 130 mg/dl and BP < 140/90 mmHg according to the ADA at the 1st and 2nd MTM were 48 (6.9%) and 51 (7.4%) respectively. According to Pearson's product moment correlation, the knowledge of medications, diabetes, and self-care management (p < 0.01, r = 0.969, r2 = 0.94), and satisfaction with the pharmacists (p < 0.01, r = 0.728, r2 = 0.53) were correlated positively with the knowledge of self-care management regarding adverse drug reactions with a statistically significant difference. In summary, the MTM system can improve clinical outcomes, raise patients’ knowledge and self-care management, and decrease the number of drug-related problems.
References
2. Jennings DL, Ragucci KR, Chumney EC, Wessell AM. Impact of clinical pharmacist intervention on diabetes-related quality-of-life in an ambulatory care clinic. Pharm Pract. 2007;5(4):169-73.
3. Home P. The challenge of poorly controlled diabetes mellitus. Diabetes Metab. 2003;29(2 Pt 1):101-9.
4. Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm. 1990;47(3):533-43.
5. Armor BL, Britton ML, Dennis VC, Letassy NA. A review of pharmacist contributions to diabetes care in the United States. J Pharm Pract. 2010;23(3):250-64.
6. Jansilasukul Y. The role of pharmacists in diabetes care of outpatient clinic at Makarak hospital [dissertation]. Bangkok: Graduate College of Mahidol University; 2002. (in Thai)
7. Kerdsiri K. Influence of the risk factors on drug-related problem
s to clinical outcome of diabetes patients in OPD clinic at Mahasarakham hospital [dissertation]. Bangkok: Graduate College of Chulalongkorn University; 2003. (in Thai)
8. Okapanom S. Drug-related problems and problem-solving outcome in DM clinic at Kasetwisai hospital [dissertation]. Mahasarakham: Mahasarakham University; 2008. (in Thai)
9. Poolsap N, Uypraserd P. Effects of pharmaceutical care on the number of drug-related problems (DRPs) and fasting blood sugar in DM clinic. SWU J Pharm Sci. 2005;10(1):10-6. (in Thai)
10. Wubben DP, Vivian EM. Effects of pharmacist outpatient interventions on adults with diabetes mellitus: a systematic review. Pharmacotherapy. 2008;28(4):421-36.
11. Jameson JP, Baty PJ. Pharmacist collaborative management of poorly controlled diabetes mellitus: a randomized controlled trial. Am J Manag Care. 2010;16(4):250-5.
12. Erku DA, Ayele AA, Mekuria AB, Belachew SA, Hailemeskel B, Tegegn HG. The impact of pharmacist-led medication therapy management on medication adherence in patients with type 2 diabetes mellitus: a randomized controlled study. Pharm Pract. 2017;15(3):1026.
13. Lindenmeyer A, Hearnshaw H, Vermeire E, Van Royen P, Wens J, Biot Y. Interventions to improve adherence to medication in people with type 2 diabetes mellitus: a review of the literature on the role of pharmacists. J Clin Pharm Ther. 2006;31(5):409-19.
14. Jaturapattarapong W, Sakthong P. Outcomes of medication therapy management in diabetic outpatients. Thai Pharm Health Sci J. 2013;8(4):133-42. (in Thai)
15. Lekpet J, Pitchayapaibul W. Medication therapy management for type 2 diabetic out-patients by the pharmacist. Thai Pharm Health Sci J. 2011;6(4):274-81. (in Thai)
16. Songmuang A. Songmuang P. Jampasa N. Outcome of diabetic patient management by proactive pharmaceutical care service. Srinagarind Med J. 2017;32(3):236-43. (in Thai)
17. Manadee C, Ploylearmsang C, Sookaneknun P. Effects of elderly care with chronic diseases on quality use of medicine at home in area of sub-district health promoting hospitals, Somdet District, Kalasin Province. Isan J Pharm Sci. 2014;10(3):355-71.
18. American Diabetic Association [Internet]. Professional practice guideline [cited 2017 Dec 1]. Available from http://care.diabetesjournals.org/content/diacare/suppl/2016/12/15/40supplement_1.DC1/DC_40_S1_final.pdf
19. Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP, Fleisher LA, Jneid H, Mack MJ, McLeod CJ, O’Gara PT, Rigolin VH, Sundt TM, Thompson A. 2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2017;70(2):252-89.
20. American Pharmacists Association and National Association of Chain Drug Stores Foundation. Medication therapy management in pharmacy practice: core elements of an MTM service model (version 2.0). J Am Pharm Assoc. 2008; 48(3):341-53.
21. Cipolle RJ, Strand LM, Morley PC. Pharmaceutical care defined. Pharmaceutical care practice: the clinician’s guide. New York. McGraw-Hill; 2004.
22. Garcia AA, Villagomez ET, Brown SA, Kouzekanani K, Hanis CL. The Starr County Diabetes Education Study: development of the Spanish-language diabetes knowledge questionnaire. Diabetes Care. 2001;24(1):16-21.
23. Schmitt A, Gahr A, Hermanns N, Kulzer B, Huber J, Haak T. The Diabetes Self-Management Questionnaire (DSMQ): development and evaluation of an instrument to assess diabetes self-care activities associated with glycaemic control. Health and quality of life outcomes. 2013;11:138.
24. Schmitt A, Reimer A, Hermanns N, Huber J, Ehrmann D, Schall S, et al. Assessing Diabetes Self-Management with the Diabetes Self-Management Questionnaire (DSMQ) Can Help Analyse Behavioural Problems Related to Reduced Glycaemic Control. PloS One. 2016;11(3):e0150774.
25. Supachaipanichpong P, Watanasomboon P, Tunsakul S, Chumcheun P. Knowledge and beliefs in medication use among diabetic patients. Veridian E-j Sci Technol Silpakorn Univ. 2014; 1(1):1-12. (in Thai)
26. Traverso ML, Salamano M, Botta C, Colautti M, Palchik V, Perez B. Questionnaire to assess patient satisfaction with pharmaceutical care in Spanish language. Int J Qual Health Care. 2007;19(4):217-24.
27. The ultimate IBM® SPSS® Statistics guides. One-way ANOVA [Internet]. 2013 [cited 2018 Apr 4]. Available from: https://statistics.laerd.com/statistical-guides/one-way-anova-statistical-guide.php
28. Garcia AA, Villagomez ET, Brown SA, Kouzekanani K, Hanis CL. The Starr County Diabetes Education Study: development of the Spanish-language diabetes knowledge questionnaire. Diabetes care. 2001;24(1):16-21.
29. Schmider E, Ziegler M, Danay E, Beyer L, Bühner M. Is It Really Robust? Methodol. 2010;6(4):147-51.
30. Osborne JW. Is data cleaning and the testing of assumptions relevant in the 21st century? Front Psychol. 2013;4.
31. Al-Ghamdi AA. Role of HbA1c in management of diabetes mellitus. Saudi Med J. 2004;25(3):342-5.
32. Sherwani SI, Khan HA, Ekhzaimy A, Masood A, Sakharkar MK. Significance of HbA1c Test in Diagnosis and Prognosis of Diabetic Patients. Biomarker Insights. 2016;11:95-104.
33. Coons SJ. Health outcomes and quality of Life. In: Dipiro JT, Talbert RL, Yee GC, Matzke GR, Wells BG, Posey LM, editors. Pharmacotherapy: a pathophysiologic approach. New York. McGraw-Hill, 2008: p.3.
34. Kozma CM, Reeder CE, Schulz RM. Economic, clinical, and humanistic outcomes: a planning model for pharmacoeconomic research. Clin Ther. 1993;15(6):1121-32.
35. Martin F, Camfield L, Rodham K, Kliempt P, Ruta D. Twelve years’ experience with the Patient Generated Index (PGI) of quality of life: a graded structured review. Qual Life Res. 2007;16(4):705-15.
36. Ruta DA, Garratt AM, Leng M, Russell IT, MacDonald LM. A new approach to the measurement of quality of life. The Patient-Generated Index. Medical care. 1994;32(11):1109-26.
Downloads
Published
How to Cite
Issue
Section
License
All articles published and information contained in this journal such as text, graphics, logos and images is copyrighted by and proprietary to the Thai Bulletin of Pharmaceutical Sciences, and may not be reproduced in whole or in part by persons, organizations, or corporations other than the Thai Bulletin of Pharmaceutical Sciences and the authors without prior written permission.
